Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gennaro Musi

Showing results (51-60 of 265) with videos related to

Pageof 27
Sort By:
Plos One|July 18, 2013
Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) significantly improve prostate cancer detection at initial biopsy in a total PSA range of 2-10 ng/mlMatteo Ferro, Dario Bruzzese, Sisto Perdonà, et al.
Minerva Urology and Nephrology|August 2, 2024
Lower PHI, [-2]proPSA/fPSA and testosterone/estradiol ratios in healthy black men: preliminary results and potential implications in prostate cancer clinical managementMatteo Ferro, Ottavio De Cobelli, Felice Crocetto, et al.
Urologic Oncology|March 23, 2026
Tumor size effect on cancer-specific mortality in T2N0M0 urothelial bladder cancer treated with trimodal therapyNick J Lee, Federico Polverino, Leonardo Quarta, et al.
Urologic Oncology|March 21, 2015
Body mass index was associated with upstaging and upgrading in patients with low-risk prostate cancer who met the inclusion criteria for active surveillanceOttavio de Cobelli, Daniela Terracciano, Elena Tagliabue, et al.
Tumori|May 10, 2024
Muscle-invasive bladder cancer in elderly and frail people: Is hypofractionated radiotherapy a feasible approach when no other local options are available?Giulia Marvaso, Angelo Vitullo, Giulia Corrao, et al.
Therapeutic Advances in Urology|April 18, 2018
Meta-analysis of studies comparing oncologic outcomes of radical prostatectomy and brachytherapy for localized prostate cancerGabriele Cozzi, Gennaro Musi, Roberto Bianchi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 20, 2024
First-in-human validation of a DROP-IN β-probe for robotic radioguided surgery: defining optimal signal-to-background discrimination algorithmFrancesco Collamati, Silvio Morganti, Matthias N van Oosterom, et al.
World Journal of Urology|December 4, 2017
Thulium-yttrium-aluminium-garnet (Tm:YAG) laser treatment of penile cancer: oncological results, functional outcomes, and quality of lifeGennaro Musi, Andrea Russo, Andrea Conti, et al.
Radiology|July 29, 2025
Histopathologic Yields and Concordance of In-Bore MRI-targeted Biopsy for Prostate Cancer DiagnosisCaterina Sattin, Caterina Pizzi, Paul Summers, et al.
World Journal of Urology|July 13, 2019
Conditional survival of patients with stage I-III squamous cell carcinoma of the penis: temporal changes in cancer-specific mortalityFrancesco Alessandro Mistretta, Carlotta Palumbo, Sophie Knipper, et al.
Pageof 27

Showing results (51-60 of 265) with videos related to

Sort By:
Pageof 27
Plos One|July 18, 2013
Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) significantly improve prostate cancer detection at initial biopsy in a total PSA range of 2-10 ng/mlMatteo Ferro, Dario Bruzzese, Sisto Perdonà, et al.
Minerva Urology and Nephrology|August 2, 2024
Lower PHI, [-2]proPSA/fPSA and testosterone/estradiol ratios in healthy black men: preliminary results and potential implications in prostate cancer clinical managementMatteo Ferro, Ottavio De Cobelli, Felice Crocetto, et al.
Urologic Oncology|March 23, 2026
Tumor size effect on cancer-specific mortality in T2N0M0 urothelial bladder cancer treated with trimodal therapyNick J Lee, Federico Polverino, Leonardo Quarta, et al.
Urologic Oncology|March 21, 2015
Body mass index was associated with upstaging and upgrading in patients with low-risk prostate cancer who met the inclusion criteria for active surveillanceOttavio de Cobelli, Daniela Terracciano, Elena Tagliabue, et al.
Tumori|May 10, 2024
Muscle-invasive bladder cancer in elderly and frail people: Is hypofractionated radiotherapy a feasible approach when no other local options are available?Giulia Marvaso, Angelo Vitullo, Giulia Corrao, et al.
Therapeutic Advances in Urology|April 18, 2018
Meta-analysis of studies comparing oncologic outcomes of radical prostatectomy and brachytherapy for localized prostate cancerGabriele Cozzi, Gennaro Musi, Roberto Bianchi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 20, 2024
First-in-human validation of a DROP-IN β-probe for robotic radioguided surgery: defining optimal signal-to-background discrimination algorithmFrancesco Collamati, Silvio Morganti, Matthias N van Oosterom, et al.
World Journal of Urology|December 4, 2017
Thulium-yttrium-aluminium-garnet (Tm:YAG) laser treatment of penile cancer: oncological results, functional outcomes, and quality of lifeGennaro Musi, Andrea Russo, Andrea Conti, et al.
Radiology|July 29, 2025
Histopathologic Yields and Concordance of In-Bore MRI-targeted Biopsy for Prostate Cancer DiagnosisCaterina Sattin, Caterina Pizzi, Paul Summers, et al.
World Journal of Urology|July 13, 2019
Conditional survival of patients with stage I-III squamous cell carcinoma of the penis: temporal changes in cancer-specific mortalityFrancesco Alessandro Mistretta, Carlotta Palumbo, Sophie Knipper, et al.
Pageof 27